Stefano Buono on Turning Nuclear Physics into Real-World Impact
"As a scientist, I have always been driven by curiosity — the desire to see an idea move from the blackboard to real impact in the world. The transition from researcher to entrepreneur begins with a simple but profound question: can this discovery solve a real problem? Once you find that connection between scientific potential and societal need, everything else becomes a matter of building the right ecosystem around it.
When I founded Advanced Accelerator Applications (AAA), my goal was to translate decades of nuclear physics research into tangible medical innovations. At CERNDealroom has a profile for this one. Try Dealroom →, where I worked for many years, we had access to extraordinary talent and cutting-edge accelerator technologies, but the challenge was to move beyond pure research and build a business that could deliver new treatments to patients. The key was to combine scientific rigor with entrepreneurial pragmatism — to take the same precision we apply in experiments and direct it toward creating value and improving lives.
AAA grew out of a strong scientific foundation but succeeded thanks to a multidisciplinary mindset: physicists, chemists, clinicians, engineers, and business professionals working together toward a common purpose. Our collaboration with academic and medical institutions across Europe — from research hospitals to nuclear medicine departments — was essential in developing and validating new radiopharmaceuticals. Lutathera, our most advanced product, is a perfect example: it originated from fundamental research in radiolabeling and targeting, evolved through close clinical partnerships, and eventually became a life-changing therapy for patients with neuroendocrine tumors. The acquisition by Novartis in 2018 was not only a financial milestone but also the recognition that rigorous science, when paired with persistence and collaboration, can truly reach the global stage.
With newcleo, we are once again applying the same philosophy — bridging scientific innovation and industrial execution — but this time to the field of sustainable nuclear energy. Our mission is to accelerate the transition to clean, safe, and circular nuclear power, using advanced lead-cooled fast reactors and closed fuel cycles. As with AAA, we are building on decades of research carried out in national laboratories and universities across Europe. The difference now is the scale and urgency: decarbonization demands that we move faster, and that we align innovation with societal responsibility from the very start.
Partnerships with universities and research centers are at the heart of this journey. They provide not only access to exceptional minds and state-of-the-art infrastructure but also an ongoing dialogue between discovery and application. For a deep-tech company, these relationships are not optional — they are the lifeblood of innovation.
If I had to share one message with scientists who dream of becoming entrepreneurs, it would be this: don’t wait for perfect conditions. Start small, test your ideas in the real world, and build a network of people who complement your skills. Science gives us the tools to understand reality; entrepreneurship gives us the means to change it. The most rewarding path lies at their intersection.”
Source: Stefano BuonoDealroom has a profile for this one. Try Dealroom →
Image source: Fortune
J.V.